References Tesamorelin LiverTox: Clinical and Research Information on Drug-Induced Liver Injury National Institutes of Health, NIDDK (2018) Tesamorelin (Subcutaneous route) Drug Information Mayo Clinic / IBM Merative (2025) Effects of tesamorelin (TH9507), a growth hormonereleasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two phase 3 trials J
Li J, Peng X, Zhong H, Liu S, Shi J, Zhou X, et al
Individuals with a higher starting weight or body mass index (BMI) may experience greater weight loss
Klinic manages everything from insurance verification to ongoing care coordination, leaving you to focus entirely on achieving your health aspirations
This research suggests that mimicking the action of the GLP1 hormone may have potential to improve blood flow through microvessels and perhaps one day could have a role in heart attack treatment